New Diabetes Combo Agent Gets FDA Nod
(medpagetoday.co) (MedPage Today) -- The FDA has approved Jentadueto, a combination of metformin plus a dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes, makers of the drug announced.
Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15786 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15786]
updated 15786 (Medical - Nephrology), inserted 15, updated 0, at 2012-05-31 07:09:15
Articles from: Medical - Nephrology (medpagetoday.co)